Booster doses of COVID-19 vaccines for patients with haematological and solid cancer: a systematic review and individual patient data meta-analysis

IMPORTANCE: Patients with cancer have an increased risk of severe disease and mortality from COVID-19, as the disease and antineoplastic therapy cause reduced vaccine immunogenicity. Booster doses have been proposed to enhance protection, and efficacy data are emerging from several studies. OBJECTIV...

Descripción completa

Detalles Bibliográficos
Autores principales: Mai, Aaron Shengting, Lee, Ainsley Ryan Yan Bin, Tay, Ryan Yong Kiat, Shapiro, Lauren, Thakkar, Astha, Halmos, Balazs, Grinshpun, Albert, Herishanu, Yair, Benjamini, Ohad, Tadmor, Tamar, Shroff, Rachna T., LaFleur, Bonnie J., Bhattacharya, Deepta, Peng, Siyu, Tey, Jeremy, Lee, Soo Chin, Chai, Louis Yi Ann, Soon, Yu Yang, Sundar, Raghav, Lee, Matilda Xinwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163022/
https://www.ncbi.nlm.nih.gov/pubmed/35753213
http://dx.doi.org/10.1016/j.ejca.2022.05.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163022/
https://www.ncbi.nlm.nih.gov/pubmed/35753213
http://dx.doi.org/10.1016/j.ejca.2022.05.029

Ejemplares similares